Show simple item record

dc.contributor.authorGierut, J. J.
dc.contributor.authorHaigis, K. M.
dc.contributor.authorJacks, Tyler E.
dc.date.accessioned2018-06-25T18:21:01Z
dc.date.available2018-06-25T18:21:01Z
dc.date.issued2014-03
dc.identifier.issn1559-6095
dc.identifier.urihttp://hdl.handle.net/1721.1/116575
dc.description.abstractLentiviral vectors offer versatility as vehicles for gene delivery. They can transduce a wide range of cell types and integrate into the host genome, which results in long-term expression of the transgene (Cre) both in vitro and in vivo. This protocol describes how lentiviral particles are produced, purified, and concentrated.en_US
dc.publisherCold Spring Harbor Laboratory Pressen_US
dc.relation.isversionofhttp://dx.doi.org/10.1101/PDB.PROT073437en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleProducing and Concentrating Lenti-Cre for Mouse Infectionsen_US
dc.typeArticleen_US
dc.identifier.citationGierut, J. J. et al. “Producing and Concentrating Lenti-Cre for Mouse Infections.” Cold Spring Harbor Protocols 2014, 3 (March 2014): 304-306 © 2014 Cold Spring Harbor Laboratory Pressen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorJacks, Tyler E.
dc.relation.journalCold Spring Harbor Protocolsen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-06-25T17:12:22Z
dspace.orderedauthorsGierut, J. J.; Jacks, T. E.; Haigis, K. M.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-5785-8911
dspace.mitauthor.errortrue
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record